Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
- PMID: 28669140
- PMCID: PMC5497668
- DOI: 10.3350/cmh.2017.0107
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Keywords: Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Metronomic chemotherapy; Sorafenib.
Conflict of interest statement
Comment on
-
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function.Clin Mol Hepatol. 2017 Jun;23(2):128-137. doi: 10.3350/cmh.2016.0071. Epub 2017 May 10. Clin Mol Hepatol. 2017. PMID: 28494528 Free PMC article.
References
-
- Sullivan RD, Norcross JW, Watkins E., Jr Chemotherapy of metastatic liver cancer by prolonged hepatic artery infusion. N Engl J Med. 1964;270:321–327. - PubMed
-
- Gorgun B, Watne AL. Infusion chemotherapy in hepatoma and metastatic liver tumors. Am J Surg. 1967;113:363–368. - PubMed
-
- Patt YZ, Charnsangavei C, Yoffe B, Smith R, Lawrence D, Chuang V, et al. Hepatic arterial infusion of floxuridine, leucovorine, doxorubicin, and cisplatin for hepatocellular carcinoma: effect of hepatitis B and C viral infection on drug toxicity and patient survival. J Clin Oncol. 1994;12:1204–1211. - PubMed
-
- Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer. 2002;95:588–595. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources